International vaccine financing mechanisms appear to be effective tools for supporting immunization activities in developing countries. The PAHO Revolving Fund provides participating member countries with a means of ensuring a smooth and constant flow of quality vaccines and related supplies for their immunization programs. This study analyzes the achievements and limitations of the fund in procuring vaccines, extending coverage, and promoting quality assurance and long-term sustainability. In addition, the study analyzes the Fund’s role in the world vaccine market and considers alternative scenarios of vaccine price setting. After comparing the immunization performance of Latin America and the Caribbean region to other developing countries, the study explores the motivations of countries in utilizing the fund and whether the process allows for technological improvements to quality. It also examines whether “one price fits all” or price differentiation according to a country’s ability to pay is a more sustainable strategy. The study has found that international financing mechanisms such as the PAHO Fund can be valuable instruments contributing to the success of immunization activities, and offers recommendations so that future funding initiatives can support quality improvements and remain affordable and sustainable. Data for the study was gathered from World Bank and PAHO data, surveys for country immunization program directors, and key informant interviews with PAHO, vaccine producers, and experts in vaccine financing. The work was performed under contract with the Gates Foundation Children’s Vaccine Program at PATH-as a contribution to the Global Alliance for Vaccines and Immunization Task Force on Financing.
Learning Objectives: This presentation will allow participants to 1) describe the nature of the PAHO Revolving Fund and the package of services provided to countries in the region, 2) gain awareness of the performance of Latin American countries in immunization quality and coverage and understand the motivations of Latin American countries in utilizing (or not utilizing) the Fund, and 3) describe various pricing scenarios and their link to a more sustainable vaccine strategy
Keywords: Immunizations, Financing
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.